Jeffrey A Schmidt

US Patent:

D669315, Oct 23, 2012

Filed:

Sep 1, 2011

Appl. No.:

29/400769

Inventors:

Paul D. Schewe - Lake Zurich IL, US
Jeffrey A. Schmidt - Libertyville IL, US

International Classification:

0701

US Classification:

D 76191

US Patent:

D4380924, Feb 27, 2001

Filed:

Aug 6, 1999

Appl. No.:

D/108983

Inventors:

Jeffrey A. Schmidt - Aurora IL

International Classification:

0805

US Classification:

D 8373

US Patent:

20210023012, Jan 28, 2021

Filed:

Apr 1, 2020

Appl. No.:

16/837576

Inventors:

- North Chicago IL, US
Hoi Kei Lon - North Chicago IL, US
Sven Mensing - Ilvesheim, DE
Jeffrey Schmidt - Mount Prospect IL, US
Neha Thakre - North Chicago IL, US
Thin Yu Tu - Libertyville IL, US

Assignee:

AbbVie Inc. - North Chicago IL

International Classification:

A61K 9/24
A61P 31/14
A61K 38/06
A61K 31/454
A61K 9/28
A61K 9/20
A61K 9/50
A61K 9/48

Abstract:

The present invention features solid pharmaceutical compositions comprising Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition includes (1) a first type of film-coated granules which comprise 50 mg of Compound 1, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion; and (2) a second type of film-coated granules which comprise 20 mg of Compound 2, as well as a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant, all of which are formulated in amorphous solid dispersion.